ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
3,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4,1,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
5,1,Burns first degree,Thermal burns,Injuries by physical agents,Inj&P,N
6,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
8,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8,2,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
9,1,Burns third degree,Thermal burns,Injuries by physical agents,Inj&P,N
10,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
10,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
11,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
11,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
12,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
12,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
13,1,Exposed bone in jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
13,2,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
14,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
15,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
15,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
16,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
16,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
16,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
16,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
16,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
17,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
17,2,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
17,3,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
17,4,Wound haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
17,5,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
18,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
18,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
19,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
19,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
19,3,Stoma site hypergranulation,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
20,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
21,1,Chemical burns of eye,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
21,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
21,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
21,4,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
21,5,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
21,6,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
22,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
23,1,Argyria,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
24,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
24,2,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
25,1,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
26,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
26,2,Skin texture abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
27,1,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
28,1,Argyria,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
29,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
29,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
30,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
30,2,Penis disorder,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
31,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
32,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
32,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
33,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
33,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
